OUR TEAM

Dr. Jacob Berchuck is a board-certified Medical Oncologist and Assistant Professor in the Department of Hematology and Medical Oncology at Emory University and the Winship Cancer Institute.

Dr. Berchuck earned his undergraduate and medical degrees at Duke University. He trained in Internal Medicine at the University of California San Francisco (UCSF) Medical Center and completed his fellowship in Medical Oncology at the Dana-Farber Cancer Institute. Dr. Berchuck also received his post-doctoral research training in cancer epigenetics with Dr. Matthew Freedman at the Dana-Farber Cancer Institute. Prior to joining Emory University, Dr. Berchuck served as an Assistant Professor of Medicine at Harvard Medical School and a Medical Oncologist at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital.

In addition to caring for patients with prostate cancer at the Winship Cancer Institute, Dr. Berchuck leads a translational research lab focused on pioneering advances that transform how we care for individuals living with cancer. Core objectives of Dr. Berchuck’s research include developing biomarkers to guide treatment decisions, deciphering mechanisms of treatment resistance, and discovering novel therapeutic strategies. His research predominantly focuses on “liquid biopsies” – studying tumor biology by profiling cell-free DNA circulating in the bloodstream – working towards a future where a simple blood draw can enable real-time insights to choose the right treatment for the right patient at the right time.